Seastar Medical Holding Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Seastar Medical Holding Corporation (Nasdaq: ICU) on January 13, 2025. The report primarily serves to disclose an update to the Company's corporate presentation used for investor relations and to provide an update on the number of common shares outstanding as of December 31, 2024.
Key Financial Metrics
The filing does not provide specific financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only quantitative data disclosed is the share count.
- Common Stock Outstanding: 5,997,246 shares (as of December 31, 2024).
- Warrants Outstanding: Warrants exercisable for one share of Common Stock at $11.50 per share (Trading Symbol: ICUCW).
Material Changes
The filing does not report material changes to financial results or operations compared to prior periods. The primary updates are:
- Release of an updated corporate presentation (Exhibit 99.1).
- Confirmation of the share count as of the end of the previous calendar year.
Guidance, Outlook, and Risks
This 8-K does not contain forward-looking guidance, management commentary on future outlook, or specific risk factors. The updated corporate presentation attached as Exhibit 99.1 may contain such information, but the text of this filing explicitly states that the information furnished pursuant to Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation) for updated business strategy, product pipeline status, and any forward-looking statements not included in this filing.
- Verify the current trading price of the common stock (ICU) and warrants (ICUCW) relative to the $11.50 warrant exercise price.
- Confirm the total share count of 5,997,246 against recent market data to ensure no subsequent issuances or buybacks have occurred since December 31, 2024.